Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis — Stella

Home/Immune Checkpoint Inhibitors-induced Colitis/

View on ClinicalTrials.gov

Recruiting

Back to Immune Checkpoint Inhibitors-induced Colitis trials

Trial locations(1 site)

Italy

SC Medicina Generale 1, Fondazione IRCCS Policlinico san Matteo, Pavia, Pavia

Key details

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Enrollment target

~250 participants

Started

July 2022

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.